Mark Leschly, 10% Owner at Cara Therapeutics, Inc. (CARA), bought 500,000 shares at $18.19 ($9.1M) on 2017-03-31, disclosed to the SEC on 2017-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| BFLY | BUY | 2012-11-15 | $299K | — | Filing → |
| ANAC | BUY | 2010-12-01 | $12.0M | — | Filing → |
| AVNC | BUY | 2007-04-16 | $2.8M | — | Filing → |